North America Neurodegenerative Disease Market

North America Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) and By Country(US, Canada) Forecasts, 2022-2030

Report Code: SRHI3178DR

Last Updated : Nov 14, 2022

Author : Straits Research

Starting From

USD 1850

Buy Now

Download Free Sample

Market Segmentation

North America Neurodegenerative Disease Market, By Indication Type (2020-2030)

Parkinson's Disease
Alzheimer's Disease
Multiple Sclerosis
Huntington Disease
Amyotrophic Lateral Sclerosis
Spinal Muscular Atrophy (SMA)
Other Indication Types

North America Neurodegenerative Disease Market, By Drug Type (2020-2030)

N-methyl-D-aspartate Receptor antagonists
Cholinesterase Inhibitors
Dopamine Agonists
Immunomodulatory Drugs
Acetylcholinesterase (AChE) Inhibitors
Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
Catechol-O-Methyltransferase (COMT) Inhibitor
SSRIs
Other Drug Types

Related Reports

Regenerative Medicine Market

Global Report

Regenerative Medicine Market Size The global regenerative medicine market size is estimated to be worth USD 19.80 billion in 2024 and is projected to reach from USD 24.88 billion in 2025 to USD 148.42 billion by 2033, growing at

Buy Now

Purchase Benefits

Eligible for a free updated report next year
Completely customizable scope
30% discount on your next purchase
Dedicated account manager
Query resolution within 24 hours
Permission to print the report

Market Segmentation

Related Reports

Purchase Benefits

We are featured on :

Sample Details